Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record's timestamps were updated, adding June 2026 updates and removing earlier March–April entries, reflecting routine registry maintenance rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-19T17:39:10.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now indicates recruitment has ended and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading is updated and the revision note updated to v3.6.0, replacing the earlier label.
    Difference
    0.1%
    Check dated 2026-06-12T11:41:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a newer revision label (v3.5.5) replacing the previous v3.5.4, indicating an updated page version. This is a versioning update rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-06-05T08:43:30.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small update to the page's version label rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-05-15T04:14:44.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.3, replacing v3.5.2. This represents an internal metadata update with no changes to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T18:25:17.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added, replacing the previous Revision: v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:31:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.